Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Transl J Am Coll Sports Med. 2021 Fall;6(4):e000180. doi: 10.1249/tjx.0000000000000180

Table 1.

Women cancer survivors participating in a proof-of-concept implementation pilot study

Variable Women Cancer Survivors (N=16)a

Age (years) 58 ± 12 (37 – 83)
Ethnicity
 Not Hispanic/Latino 11 (100)
Race
 White/Caucasian 10 (62)
 Black/African American 6 (38)
Income
 ≤ $20,000 5 (31)
 > $20,000 to < $50,000 4 (25)
 ≥ $50,000 6 (38)
 Missing 1 (6)
Education
 ≤ 12 years 5 (31)
 13 – 16 years 6 (38)
 > 16 years 5 (31)
Mean number of comorbidities 2.5 ± 1.6 (0 – 5)
Marital status
 Married 11 (69)
 Not married or partnered 5 (31)
Current smoker (yes) 0 (0)
Alcohol (yes) 3 (19)
Cancer type
 Breast 11 (69)
 Other (melanoma, lung, leukemia, uterine, cervical) 5 (31)
Cancer stage
 0 or 1 4 (25)
 2 7 (44)
 3 2 (12)
 Missing or unknown 3 (19)
Months since cancer diagnosis 54 ± 72 (11 to 300)
Prior cancer surgery (yes) 14 (88)
Prior radiation therapy (yes) 11 (69)
Prior chemotherapy (yes) 10 (63)
Distance from home to implementation site b 10 ± 10 (3 – 35)
Distance from job to implementation site b, c 11 ± 15 (0 – 40)
a

Values presented as mean ± standard deviation (range) or number (percent).

b

Distance from home and job to the implementation site reported in miles.

c

Participants who were employed (n = 7).